CompareAEYE HealthvsEyenuk

AEYE Health is an AI retinal diagnostics company providing autonomous and assistive analysis for diabetic retinopathy screening in primary care settings. The product is positioned around retinal screening and care routing rather than ophthalmologist replacement, and specialist follow-up remains essential for every positive screen surfaced through the workflow. Buyers should confirm regulatory clearance, camera and imaging hardware compatibility, downstream referral integration, and program reporting before launching diabetic eye screening across primary care sites today.

AEYE Health works best for primary care diabetic retinopathy screening. The product's edge is lightweight retinal screening deployment, though buyers must accept that buyer scope is narrower than imaging ai giants. Pricing is sales-led and scoped per buyer rather than posted publicly. Run a small pilot to confirm fit before committing to a wider rollout.

Eyenuk is an AI eye-screening company offering autonomous detection of diabetic retinopathy, diabetic macular edema, and related retinal conditions. The product is positioned around retinal screening and care routing rather than ophthalmologist replacement, and specialist follow-up remains essential for every positive screen surfaced through the workflow. Buyers should confirm regulatory clearance, camera and imaging hardware compatibility, downstream referral integration, and program reporting before launching diabetic eye screening across primary care sites today.

The clearest fit for Eyenuk is diabetic and multi-disease eye screening programs, with the platform leaning into multi-disease retinal screening focus. Limitations are real: workflow placement is clinic-specific. Pricing is sales-led and scoped per buyer rather than posted publicly. Buyers should confirm validation depth, support coverage, and rollout plan before signing.